Meta-analysis or comparative efficacy review of tirzepatide, retatrutide, and semaglutide for weight loss in obese individuals without diabetes. Synthesizes clinical trial data across all three agents to compare percent body weight reductions, response rates, and tolerability profiles. Provides a head-to-head efficacy landscape for the current generation of incretin-based weight loss therapies.
Olowo-Oribi, Bastu Adebayo; Salway, Richard James